Experimental Brain Research

, Volume 230, Issue 4, pp 597–604 | Cite as

In vivo oxymetric analysis of mild hypercapnia upon cerebral oxygen, temperature and blood flow: markers of mood as proposed by concomitant bupropion challenge and electrochemical analysis?



Scientific interest has increased the influence of temperature in neurodegenerative and psychiatric disorders, and according to the monoamine hypothesis, depression is a neurochemical disorder arising from hypofunctioning of brain monoamine systems. Here, in vivo flow–oxymetry is applied to verify relationships between cerebral oxygen tension (pO2), blood flow (CBF), that are markers of brain metabolism, and temperature (T), while in vivo voltammetry is concomitantly applied in the medial prefrontal cortex of anaesthetized rats to monitor monoamine levels such as dopamine (DA) and serotonin. An induced mild hypercapnia via increasing exogenous carbon dioxide (CO2) concentration resulted in increased pO2, CBF and T in discrete brain areas. Concomitant in situ voltammetric analysis of extracellular levels of serotonin and DA has revealed significant changes in the latter, only. Parallel treatment with antidepressant bupropion has confirmed its described central thermogenic properties and its positive influence on dopaminergic activity. CBF was also enhanced by such antidepressant. Altogether these data support direct relationships between markers of brain metabolism such as pO2, CBF, T and brain monoamine[s], indicating the coupled in vivo methodology: oxymetry–voltammetry as a rapid in vivo tool for analyses of such indicators in psychiatric disorders.


Cerebral blood flow Tissue oxygen tension Brain temperature Mood In vivo oxymetry–voltammetry Rat brain 


  1. Ascher JA, Cole JO, Colin JN (1995) Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56:395–401PubMedGoogle Scholar
  2. Blatteis C (1998) Physiology and pathophysiology of temperature and regulation. World Scientific Printers, SingaporeCrossRefGoogle Scholar
  3. Bonhomme N, Esposito E (1998) Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J Clin Psychopharmacol 18:447–454PubMedCrossRefGoogle Scholar
  4. Brian JE Jr (1998) Carbon dioxide and the cerebral circulation. Anesthesiology 88:1365–1386PubMedCrossRefGoogle Scholar
  5. Cooper BR, Hester TJ, Maxwell RA (1980) Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 215:127–134PubMedGoogle Scholar
  6. Crespi F (2009) Apamin increases 5-HT cell firing in raphe dorsalis and extracellular 5-HT levels in amygdala: a concomitant in vivo study in anaesthetized rats. Brain Res 1281:35–46PubMedCrossRefGoogle Scholar
  7. Crespi F, Martin KF, Marsden CA (1988) Nafion coated carbon fibre electrodes combined with differential pulse voltammetry measure 5-HT release in vivo. Neuroscience 27:885–896PubMedCrossRefGoogle Scholar
  8. Dahlgren N, Lindvall O, Nobin A, Stenevi U (1981) Cerebral circulatory response to hypercapnia: effects of lesions of central dopaminergic and serotoninergic neuron systems. Brain Res 230(1–2):221–233PubMedCrossRefGoogle Scholar
  9. Davis TL, Kwong KK, Weisskoff RM, Rosen BR (1998) Calibrated functional MRI: mapping the dynamics of oxidative metabolism. Proc Natl Acad Sci USA 95:1834–1839PubMedCrossRefGoogle Scholar
  10. Dulloo AG, Miller DS (1987) Screening of drugs for thermogenic anti-obesity properties: antidepressants. Ann Nutr Metab 31:69–80PubMedCrossRefGoogle Scholar
  11. Ferris RM, Cooper BR (1993) Mechanism of antidepressant activity of bupropion. J Clin Psychiatry Monogr 11(1):2–14Google Scholar
  12. Gibbs FA, Gibbs EL, Lennox WG (1935) Changes in human cerebral blood flow consequent on alterations in blood gases. Am J Physiol 111:557–563Google Scholar
  13. Hasegawa H, Meeusen R, Sarre S, Diltoer M, Piacentini MF, Michotte VJ (2005) Acute dopamine/norepjnephrjne reuptake inhibition increases brain and core body temperature in rats. J Appl Physiol 99:1397–1401PubMedCrossRefGoogle Scholar
  14. Heh W, Herrera J, DeMet E (1988) Neuroleptic induced hypothermia associated with amelioration of psychosis in schizophrenia. Neuropsychopharmacology 1(1):149–156PubMedCrossRefGoogle Scholar
  15. Hemphill J, Knudson C, Derugin N, Morabito DRN, Manley GT (2001) Carbon dioxide reactivity and pressure autoregulation of brain tissue oxygen. Neurosurgery 48:377–384PubMedGoogle Scholar
  16. Hoge RD (1999) Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson Med 42:849–863PubMedCrossRefGoogle Scholar
  17. Kim SG, Rostrup E, Larsson HB, Ogawa S, Paulson OB (1999) Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation. Magn Reson Med 41:1152–1161PubMedCrossRefGoogle Scholar
  18. Kudoh A, Tkase H, Takazawa T (2003) Chronic treatment with antidepressants decreases intraoperative core hypothermia. Anaesth Analg 97:275–279CrossRefGoogle Scholar
  19. Lassen NA (1959) Cerebral blood flow and oxygen consumption in man. Physiol Rev 39:183–238PubMedGoogle Scholar
  20. Lennox WG, Gibbs EL (1932) The blood flow in the brain and the leg of man, and the changes induced by alteration of blood gases. J Clin Investig 11:1155–1177PubMedCrossRefGoogle Scholar
  21. Lerer B (1985) Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biol Psychiatry 121:20–40CrossRefGoogle Scholar
  22. Li SX, Perry KW, Wong DT (2002) Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of the rat. Neuropharmacology 42:181–190PubMedCrossRefGoogle Scholar
  23. Liu L, Connoly P, Harrison J, Heal D, Stock MJ (2004) Pharmacological characterization of the thermogenic effect of buproprion. Eur J Pharmacol 498:219–225PubMedCrossRefGoogle Scholar
  24. Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7:541–547PubMedCrossRefGoogle Scholar
  25. Nioka S (1987) Relationship between intracellular pH and energy metabolism in dog brain as measured by 31P–NMR. J Appl Physiol 62:2094–2102PubMedGoogle Scholar
  26. Nomikos GC, Damsma G, Wenkstern D (1989) Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology 2:273–279PubMedCrossRefGoogle Scholar
  27. Nomikos GC, Damsma G, Wenkstern D (1992) Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 7:7–14PubMedGoogle Scholar
  28. Okumura A, Nakano T, Fukumoto Y, Higuchi K, Kamiya H, Watanabe K (2005) Delirious behavior in children. Brain Dev 27(4):271–274PubMedCrossRefGoogle Scholar
  29. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Plenum, New YorkGoogle Scholar
  30. Ren M, Senatorov V, Chen R, Chuang D (2003) Post-insult treatment with lithium reduces brain damage and facilitates neurological recovery in rat ischemia/reperfusion model. Mol Neurobiol Sect 100:6210–6215Google Scholar
  31. Rush AJ, Giles DE, Schlesser MA (1996) The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 57:470–484PubMedCrossRefGoogle Scholar
  32. Salerian AJ (2010) Thermodynamic laws apply to brain function. Med Hypotheses 74:270–274PubMedCrossRefGoogle Scholar
  33. Salerian AJ, Saleri NG (2005) Cooler biologically compatible core body temperatures may prolong longevity and combat neurodegenerative disorders. Med Hypotheses 66:636–642PubMedCrossRefGoogle Scholar
  34. Salerian AJ, Saleri NG, Salerian JA (2008) Brain temperature may influence mood: a hypothesis. Med Hypotheses 70:497–500PubMedCrossRefGoogle Scholar
  35. Schmidt CF (1928) The influence of cerebral blood-flow on respiration. I. The respiratory responses to changes in cerebral blood-flow. Am J Physiol 84:202Google Scholar
  36. Schmidt CF, Hendrix JP (1938) The action of chemical substances on cerebral blood-vessels. Am Res Nerv Ment Dis Proc 18:229Google Scholar
  37. Schwarz AJ (2004) Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. Neuroimage 23:296–304PubMedCrossRefGoogle Scholar
  38. Self T, Crespi F (1992) Electron microscopic and voltammetric analysis of carbon fibre electrode pretreatments. J Mater Med 3:418–425CrossRefGoogle Scholar
  39. Seymour SK, Schmidt CF (1948) The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Investig 27:484–492CrossRefGoogle Scholar
  40. Shore PA, Silver SL, Brodie BB (1955) Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science 122:284–285PubMedCrossRefGoogle Scholar
  41. Stahl SM (1998) Basic psychopharmacology of antidepressants, pt 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59(s. 4):5–14PubMedGoogle Scholar
  42. Stamford J, Crespi F, Marsden CA (1992) Practical approach series monitoring neuronal activity. Irl Press at Oxford University Press, Oxford, UK, pp 113–145Google Scholar
  43. Zheng Y (2002) A model of the hemodynamic response and oxygen delivery to brain. Neuroimage 16:617–637PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Biology DepartmentNeurosciences CEDD GlaxoSmithKline, Medicines Research CentreVeronaItaly

Personalised recommendations